Gilead Sciences

Biotechnology
GILD
$ 73 (0.44)%
Share price
$ 91 bn
Market Cap
$ 108 bn
Enterprise Value

Carbon footprint

0.78 Ton
GHG emissions per $ 1 mln investment
0.02x the weighted average for S&P 500
FY2020
How is this calculated?
+16%
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Gilead Sciences's GHG emissions (market-based) (Kt of CO2e)
Gilead Sciences's Carbon intensity (Tons per 1 USDm)

Gilead Sciences's carbon footprint

Gilead Sciences reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 84 Kt (+12/+16% y-o-y). Carbon intensity also was up at 3.4 t (+0.2/+6.2% y-o-y).

Gilead Sciences's Scope 3 emissions surged to 38 Kt (+5.1/+16% y-o-y). The growth accelerated relative to the long-term trend (+6.1% CAGR) observed since 4Q'16.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Gilead Sciences also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Gilead Sciences commits to reduce absolute scope 1 and 2 GHG emissions 46% by 2030 from a 2019 base year. Gilead Sciences also commits to reduce absolute scope 3 GHG emissions 15% over the same timeframe.

Company environmental metrics

Show more...